期刊文献+

39例弥漫大B细胞性淋巴瘤临床分析 被引量:1

下载PDF
导出
摘要 目的比较CHOP及CHOEP两种化疗方案治疗弥漫大B细胞性淋巴瘤(diffuse large B cell lymphoma,DLBCL)的疗效及其毒副反应。方法 39例初治DLBCL患者根据不同化疗方案分为CHOP方案组19例,予环磷酰胺750 mg/(m^2·d),d1;阿霉素50 mg/(m^2·d),d1;长春新碱1.4 mg/(m^2·d),d1(总量不超过2 mg);强的松100 mg/d,d1~d5。CHOEP方案组20例在CHOP方案基础上加用足叶乙甙100mg/(m^2·d),d1~d3,比较两组治疗的疗效及毒副反应。结果治疗后CHOP组患者获CR 6例,PR 9例,SD 3例,PD 0例,RR为78.9%。CHOEP组患者获CR 15例,PR 4例,SD 1例,PD 0例,RR为95.0%,两组完全缓解率比较差异有统计学意义(P<0.05)。两组患者有效率、毒副反应和2年生存率比较差异均无统计学意义(P均>0.05)。结论对于初治弥漫大B细胞性淋巴瘤,CHOEP方案比CHOP方案治疗的完全缓解率更高,且不增加毒副反应发生,不失为一种较好的化疗方案。
出处 《中国癌症防治杂志》 CAS 2015年第5期353-356,共4页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
  • 相关文献

参考文献24

  • 1Rossi D,Gaidano G.Molecular heterogeneity of diffuse large B-celllymphoma:implications for disease management and prognosis [ J].Hematology, 2002,7(4):239-252. 被引量:1
  • 2叶任高,陆再英,谢毅.内科学[M].6版.北京:人民卫生出版社,2006:384. 被引量:285
  • 3张红雨,林桐榆,姜文奇,张力,黄慧强,夏忠军,孙晓非,何友兼,管忠震.美罗华联合化疗治疗侵袭性B细胞性非霍奇金淋巴瘤的临床分析[J].癌症,2004,23(12):1681-1686. 被引量:16
  • 4黄慧强,姜文奇,王巍,周中梅,夏忠军,林旭滨,李宇红,徐瑞华,张力,徐光川,孙晓非,刘冬耕,何友兼,管忠震.EPOCH方案治疗复发和耐药中高度恶性非霍奇金淋巴瘤[J].癌症,2003,22(4):389-392. 被引量:32
  • 5Harris NL,Jaffe ES,Stein H,et al.A revised European-Americanclassification of lymphoid neoplasms:a proposal from the Interna-tional Lymphoma Study Group [j ].Blood, 1994,184( 5) : 1361-1392. 被引量:1
  • 6张之南主编..血液病诊断及疗效标准 第2版[M].北京:科学出版社,1998:434.
  • 7Shipp MA,Harrington DP, Anderson JR,et al.A predictive model foraggressive non-Hodgkin's lymphoma.The International Non-Hodgkin'sLymphoma Prognostic Factors Project[j].N Engl J Med, 1993,329(14):987-994. 被引量:1
  • 8周际昌主编..实用肿瘤内科学[M].北京:人民卫生出版社,2003:818.
  • 9孙燕.内科肿瘤学[M].北京:人民卫生出版社,2003.994-995. 被引量:145
  • 10Rodriguez J,Conde E,Gutierrez A,et al.The results of consolidationwith autologous stem-cell trasplantation in patients with peripheralT-nell lymphoma(PTCL)in first complete remission the spanish lym-col,2007,18(4):652-657. 被引量:1

二级参考文献62

  • 1陆紫敏,朱海平,修冰,付建非,薄兰君,顾凤英.TCOP联合平阳霉素治疗中高度非霍奇金淋巴瘤的临床研究[J].中国肿瘤临床,2004,31(11):617-619. 被引量:6
  • 2管忠震,喻俪华,黄小薇,徐光川,张力.小细胞肺癌以化疗为主的综合治疗观察——80例报告[J].癌症,1989,8(2):101-103. 被引量:10
  • 3李陶,周立强.弥漫性大B细胞淋巴瘤诊治进展[J].癌症进展,2006,4(5):384-390. 被引量:6
  • 4[1]Fisher RI, Gaynor ER, Dahlberg S, et al. Comparion of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma[J]. N Engi J Med, 1993,328:1002 被引量:1
  • 5[2]Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized inter-mediate and high-grade non-Hodygkin's lymphoma[J]. N Engl J Med, 1998,339:21 被引量:1
  • 6[3]Schenkein DP, Roitman D, Miller KB, et al. A phase Ⅱ multicenter trial of high dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high risk non-Hodygkin's lymphoma [J]. Biol Blood Marrow Transplant, 1997,3(1):210 被引量:1
  • 7[4]Vose JM. High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse largecell non-Hodgkin' s lymphoma[J]. Ann Oncol, 1998,9(1):1~3 被引量:1
  • 8[5]Gryn J, Johnson E, Goldman N, et al. The treatment of relapsed or refractory intermediate grade non-Hodgkin' s lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon [J]. Bone Marrow Transplant,1997,19(1):221~226 被引量:1
  • 9[6]Buzzoni R, Colleoni M, Nelli P, et al. Results of a salvage regimen in refractory or relapsed non-Hodgkin's lymphoma[J].Leuk Lymphoma, Leuk Lymphoma, 1994,14(1):121-128 被引量:1
  • 10[7]Hagemeister FB, Donato M. Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience[J]. Eur J Haematol Suppl, 2001,64(1):8~13 被引量:1

共引文献512

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部